Acetylcholine affects the spatial scale of attention: Evidence from Alzheimer's disease

Neuropsychology

Volumn 14, Issue 2, 2000, Pages 288-298

  Levy, James A ^a,c   Parasuraman, Raja ^b   Greenwood, Pamela M ^b   Dukoff, Ruth ^a   Sunderland, Trey ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b CATHOLIC UNIVERSITY OF AMERICA   (United States)

^c REHABILITATION INSTITUTE OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCARINIC RECEPTOR BLOCKING AGENT; PHYSOSTIGMINE; SCOPOLAMINE;

ACETYLCHOLINE BRAIN LEVEL; ALZHEIMER DISEASE; ARTICLE; ATTENTION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DRUG EFFECT; HUMAN; PRIORITY JOURNAL; RATING SCALE; SPATIAL DISCRIMINATION;

EID: 0033813619     PISSN: 08944105     EISSN: None     Source Type: Journal    
DOI: 10.1037/0894-4105.14.2.288     Document Type: Article

References (85)

1. Neuronal loss of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease
2. Scopolamine affects easy to discriminate targets
3. Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsy
4. Modelling dementia: Effects of scopolamine on memory and attention
5. Spatial-based and object-based attention deficits in Alzheimer's disease: Relationship to HMPAO-SPECT measures of parietal perfusion
6. Cholinergic activity and constraints on information processing
7. Effects of oral scopolamine on human stimulus evaluation
8. Size of the attentional focus and efficiency of processing
9. Effects of scopolamine on parallel and serial visual search
10. Frontoparietal cortical networks for directing attention and the eye to visual locations: Identical, independent, or overlapping neural systems?
11. A PET study of visusospatial attention
12. Superior parietal cortex activation during spatial attention shifts and visual feature conjunction
13. Inhibitory processes in covert orienting in patients with Alzheimer's disease
14. A cancellation test: Its reliability in assessing attentional deficits in Alzheimer's disease
15. Neural mechanisms of selective visual attention
16. The effect of scopolamine upon verbal memory: Evidence for an attentional hypothesis
17. Scopolamine and the control of attention in humans
18. Central cholinergic systems and cognition
19. Directed and divided attention in Alzheimer's disease: Impairment in shifting of attention to global and local stimuli
20. Visual attention and perception in patients with Huntington's disease: Comparisons with other subcortical and cortical dementias
21. Hypersensitivity to scopolamine in the elderly
22. Selective attention skills in Alzheimer's disease: Performance on graded cancellation tests varying in density and complexity
23. 'Mini-mental state': A practiced method for grading the cognitive state of patients for the clinician
24. Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer's type
25. Attentional disengagement deficit in nondemented elderly over 75 years of age
26. Controlling the focus of spatial attention during visual search: Effects of advanced aging and Alzheimer disease
27. Change in visuospatial attention over the adult lifespan
28. Age differences and similarities in the effects of cues and prompts
29. Conditions under which mean square ratios in repeated measurements designs have exact F-distributions
30. Voluntary versus automatic control over the mind's eye's movement
31. Repeated measures F tests and psychophysiological research: Controlling the number of false positives
32. Theory of attentional operation in shape identification
33. Positron emission tomographic measurements of pulvinar activity during an attention task
34. Alzheimer disease, attention, and the cholinergic system
35. Tolerance to an anticholinergic agent is paralleled by increased binding to muscarinic receptors in rat brain and increased behavioral response to a centrally active cholinomimetic
36. Neurochemistry of attention
37. Systemic nicotine from cigarette smoking modifies covert orienting in human subjects
38. An attentional grasp reflex in patients with Alzheimer's disease
39. Asymmetries in the covert orienting of visual spatial attention to spatial and nonspatial cues in Alzheimer's disease
40. Mechanisms of spatial impairment of Alzheimer's disease subgroups: Differential breakdown of directed attention to global-local stimuli
41. Mental status examination for organic mental syndrome in the elderly patient
42. Pairwise multiple comparisons in repeated measures designs
43. Cholinergic and noradrenergic modulation of thalamocortical processing
44. Actions of acetylcholine in the cerebral cortex and thalamus and implications for function
45. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease
46. Central cholinergic pathways: Neuroanatomy and some behavioral implications
47. Human brain cholinergic pathways
48. Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model
49. The effects of nicotine on spatial and non-spatial expectancies in a covert orienting task
50. Focused and divided attention in Alzheimer's disease
51. Age-related differences in visual search task performance: Relative stability of parallel but not serial search
52. Attention deficit in Alzheimer's disease is not simulated by an anticholinergic/antihistaminergic drug and is distinct from deficits in healthy aging
53. The neurochemical basis of attention
54. Visuospatial attention in dementia of the Alzheimer type
55. Attention and brain function in Alzheimer's disease: A review
56. Contributions of the pulvinar to visual spatial attention
57. Aging, selective attention, and feature integration
58. Orienting of attention
59. Attentional networks
60. The attention system of the human brain
61. Effects of parietal injury on covert orienting of attention
62. Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release
63. Impairment of spatially directed attention in patients with probable Alzheimer's disease as measured by eye movements
64. Differential cholinergic regulation in Alzheimer's patients compared to controls following chronic blockade with scopolamine: A SPECT study
65. Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls: A dose-response study
66. A feature-integration theory of attention
67. Two cortical visual systems
68. Cognitive functions of the basal forebrain cholinergic system in monkeys: Memory or attention?
69. The distribution of cerebral muscarinic acetylcholine receptors in vivo in patients with dementia: A controlled study with IQNB and single photon emission computed tomography
70. The separate and combined effects of scopolamine and nicotine on human information processing
71. An investigation of the range of cognitive impairments induced by scopolamine 0.6 mg s.c.
72. The effects of cigarette smoking and nicotine tablets upon human attention
73. Effects of nicotine on stimulus sensitivity and response bias in a visual vigilance task
74. Effects of scopolamine on stimulus sensitivity and response bias in a visual vigilance task
75. Effects of smoking on rapid visual information processing performance
76. Effects of scopolamine and nicotine on human rapid information processing: Performance
77. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain
78. The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type
79. Effects of altering brain cholinergic activity on covert orienting of attention: Comparison of monkey and human performance
80. The pontomesencephalotegmental cholinergic system does not degenerate in Alzheimer's disease
81. The effects of closed head injury, senile dementia of the Alzheimer's type, and Parkinson's disease on covert orientation of visual attention